Natalie Mayhead
About Natalie Mayhead
Natalie Mayhead is a Cell Assay Development Scientist with a strong academic background in Oncology, Cancer Biology, and Toxicology. She has held various research and scientific positions at institutions such as the University of Surrey, MedImmune, and Artios Pharma Ltd.
Current Role at MeiraGTx
Natalie Mayhead serves as a Cell Assay Development Scientist at MeiraGTx, a position she has held since 2022. In this role, she focuses on developing and optimizing cell-based assays, contributing to the advancement of gene therapies. Her work supports the company's mission to deliver innovative treatments for patients with serious diseases.
Professional Experience in Biotechnology
Prior to her current role, Natalie Mayhead worked at Artios Pharma Ltd as a Scientist since 2020. She also held a position at MedImmune as a Scientist for one year in London, UK, from 2019 to 2020. Earlier in her career, she was a Cell Culture Specialist at ANGLE plc for two months in 2018 and gained experience as a Research Assistant and Biological Laboratory Assistant at the University of Surrey.
Educational Background in Oncology and Toxicology
Natalie Mayhead earned her Doctor of Philosophy (Ph.D.) in Oncology and Cancer Biology with Radiotherapy from the University of Surrey, completing her studies from 2012 to 2017. She also holds a Master’s Degree in Toxicology from the same institution, which she achieved in 2012. Additionally, she completed her Bachelor’s Degree in Biochemistry (Neuroscience) at the University of Surrey from 2007 to 2011.
Research Experience at University of Surrey
Natalie Mayhead has extensive research experience at the University of Surrey. She worked as a Ph.D. student from 2012 to 2018 and contributed to various projects during her tenure. Her roles included serving as a Research Assistant in the Immunology laboratory from 2009 to 2010 and as a Practical Assistant from 2012 to 2018. She also worked in the Ion Beam Centre as a Biological Laboratory Assistant from 2015 to 2017.